You are here

Albert Bourla, DVM, Ph.D.

Chief Operating Officer, Pfizer

Albert Bourla is the Chief Operating Officer (COO) of Pfizer, one of the world's premier innovative biopharmaceutical companies. As COO, Albert oversees the company's commercial, strategy, manufacturing and global product development functions. He is a member of the Company's Executive Leadership Team.

Prior to being named COO, Albert was the Group President of Pfizer Innovative Health, responsible for the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. He also created the Patient and Health Impact group, which was dedicated to developing solutions for increasing patient access, demonstrating the value of our innovations, and ensuring broader business model innovation.

Albert has almost 25 years of experience with Pfizer and has held a number of senior global positions across a range of markets and disciplines. Previously, Albert was the Group President of Pfizer's Global Vaccines, Oncology and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanded the company's leadership in Vaccines. Before that, he was President and General Manager of Pfizer's Established Products business, where he led the development and implementation of strategies and tactics related to Pfizer's off-patent portfolio (including legacy brands and generics).

Albert joined Pfizer's Animal Health Division in 1993 as Technical Director of Greece. He held positions of increasing responsibility across Europe before moving to Pfizer Global Headquarters in New York in 2001 to assume the role of U.S. Group Marketing Director for Animal Health. In 2004, he became Vice President of Business Development and New Products Marketing; supervising Pfizer Animal Health global licensing and acquisition activities, as well as the unit's R&D portfolio. In 2006, he was appointed Area President of Europe, Africa and Middle East and in 2009, he assumed additional responsibilities for Asia and Pacific.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. Albert is a member of the following boards: the Pfizer Foundation, which promotes access to quality health care and the Biotechnology Innovation Organization (Bio), the world's largest biotechnology trade association, where he serves on the Executive Committee.